The University of Texas M.D. Anderson Cancer Center, Site #005 — Houston, Texas

The University of Texas M.D. Anderson Cancer Center, Site #005 is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

The University of Texas M.D. Anderson Cancer Center, Site #005 has participated in 1 clinical trials.

Therapeutic areas: Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL).

Sponsors: Ariad Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Texas M.D. Anderson Cancer Center, Site #005?

The University of Texas M.D. Anderson Cancer Center, Site #005 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Texas M.D. Anderson Cancer Center, Site #005 conducted?

The University of Texas M.D. Anderson Cancer Center, Site #005 has 1 clinical trials on record. Their work covers Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL).

Is The University of Texas M.D. Anderson Cancer Center, Site #005 accredited by Crixeo Health?

The University of Texas M.D. Anderson Cancer Center, Site #005 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Texas M.D. Anderson Cancer Center, Site #005?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.